Modulate Bio raised $0.66 million to develop small-molecule therapies for neurological disorders, including essential tremor, epilepsy, and anxiety, using controlled GABA-A receptor modulators for safer and more effective treatment.
Modulate Bio raised $0.66 million to develop small-molecule therapies for neurological disorders, including essential tremor, epilepsy, and anxiety, using controlled GABA-A receptor modulators for safer and more effective treatment.
